康泰生物 (300601.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

71.6x

EV/EBITDA

29.5x

Market Cap

CNY 14.10B

MomentumView details →

1D Return

−3.15%

YTD Return

−14.83%

RSI (14)

47.9

ValuationView details →

P/E (Fwd)

71.6x

EV/EBITDA

29.5x

Market Cap

CNY 14.10B

RSI (14)

47.9

MomentumView details →

1D Return

−3.15%

YTD Return

−14.83%

ProfitabilityView details →

Gross Margin

74.14%

Net Margin

3.06%

EBITDA Margin

17.73%

ROE (TTM)

0.84%

ROA (TTM)

0.58%

Asset Turnover

0.19x

GrowthView details →

Revenue YoY

−6.55%

EPS YoY

−54.09%

FCF YoY

+9.48%

Revenue CAGR 3Y

−5.40%

EPS CAGR 3Y

−72.09%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.02

EPS Surprise

0.10%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.04

Avg Surprise (4Q)

0.10%

Rev Surprise

−0.87%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

2.87x

Quick Ratio

2.54x

Div Yield

0.28%

Div Rate

CNY 0.04

Div Growth 1Y

−61.11%

Financials snapshotView financials →

Revenue (TTM)

2.66B

Net Income (TTM)

81.24M

Op. CF (TTM)

582.60M

Next earningsOct 23, 2026 →

Latest newsMore news →

Kangtai Biological Products announced an interim dividend for the first half of 2026 of 0.27 yuan per 10 shares (pre-tax), totaling 30 million yuan, representing 59.85% of the period's net profit.14d ago

Kangtai Biological Products announced its first-half 2026 results: revenue of 1.273 billion yuan, down 8.55% year-on-year; net profit attributable to shareholders of 50.3861 million yuan, up 34.25% year-on-year.14d ago

Similar companies

双欣材料001369.SZ 安科生物300009.SZ 闰土股份002440.SZ 晶瑞电材300655.SZ 广生堂300436.SZ 汉钟精机002158.SZ Find similar companies →

Latest newsMore news →

Kangtai Biological Products announced an interim dividend for the first half of 2026 of 0.27 yuan per 10 shares (pre-tax), totaling 30 million yuan, representing 59.85% of the period's net profit.14d ago Kangtai Biological Products announced its first-half 2026 results: revenue of 1.273 billion yuan, down 8.55% year-on-year; net profit attributable to shareholders of 50.3861 million yuan, up 34.25% year-on-year.14d ago Kangtai Biological's vice president Gan Jianhui resigned due to personal health reasons.65d ago